CERE-135

N/A

Report date: 2026/02/27 12:00:29

Base Information

Drug NameCERE-135
Drug Alias NameCERE-135CERE135
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeregene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeregene Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A